Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative romiplostim in thrombocytopenic patients undergoing cardiac surgery
2024-517710-15-00Phase 2Authorised
- Sponsor
- CHU de Nantes
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Thrombocytopenia comparing Romiplostim preoperative arm with Placebo preoperative arm (2 arms). Primary endpoint: Lowest platelet count between end of extracorporeal circulation and postoperative day 7. Planned start Jul 2026; status: authorised.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on 2024-517710-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517710-15-00.